Literature DB >> 11856867

Fibroblast growth factor receptor 2 (FGFR2): genomic sequence and variations.

R G Ingersoll1, W A Paznekas, A K Tran, A F Scott, G Jiang, E W Jabs.   

Abstract

Fibroblast growth factor receptors (FGFRs) play an important role in development and tumorigenesis. Mutations in FGFR2 cause more than five craniosynostosis syndromes. The FGFR2 genomic structure is the largest of the FGFR family. We have refined and extended the genomic organization of the FGFR2 gene by sequencing more than 119 kb of PACs, cosmids, and PCR products and assembling a region of approximately 175 kb. Although the gene structure has been reported to include only 20 exons, we have verified the presence of at least 22 exons, some of which are alternatively spliced. The sizes of six exons differed from those reported previously. Comparison of our sequence and those in the NCBI database detected more than 300 potential single nucleotide polymorphisms (SNPs). However, sequencing regions containing 52 of these potential SNPs verified only 14 in PCR products generated from 16 CEPH alleles. In contrast, direct sequencing of the CEPH DNAs revealed 21 other polymorphisms. Only one SNP was found in the 2,926 bp of coding sequence. Twenty-seven SNPs, two insertion polymorphisms and five microsatellite polymorphisms are contained in approximately 16.6 kb of non-coding sequence. These data yield an average of one polymorphism for approximately 488 bp of non-coding sequence examined. This collection of SNP, insertion, and repeat polymorphisms will aid future association studies between the FGFR2 gene and human disease and will enhance mutation detection. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11856867     DOI: 10.1159/000048802

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  11 in total

1.  Mutation c.943G>T (p.Ala315Ser) in FGFR2 Causing a Mild Phenotype of Crouzon Craniofacial Dysostosis in a Three-Generation Family.

Authors:  Luitgard M Graul-Neumann; Eva Klopocki; Nicolai Adolphs; Martin A Mensah; Wolfram Kress
Journal:  Mol Syndromol       Date:  2017-01-13

2.  Expanding the mutation spectrum in 182 Spanish probands with craniosynostosis: identification and characterization of novel TCF12 variants.

Authors:  Beatriz Paumard-Hernández; Julia Berges-Soria; Eva Barroso; Carlos I Rivera-Pedroza; Virginia Pérez-Carrizosa; Sara Benito-Sanz; Eva López-Messa; Fernando Santos; Ignacio I García-Recuero; Ana Romance; Juliana María Ballesta-Martínez; Vanesa López-González; Ángel Campos-Barros; Jaime Cruz; Encarna Guillén-Navarro; Jaime Sánchez Del Pozo; Pablo Lapunzina; Sixto García-Miñaur; Karen E Heath
Journal:  Eur J Hum Genet       Date:  2014-10-01       Impact factor: 4.246

3.  Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis.

Authors:  Shih-hsin Kan; Navaratnam Elanko; David Johnson; Laura Cornejo-Roldan; Jackie Cook; Elsa W Reich; Susan Tomkins; Alain Verloes; Stephen R F Twigg; Sahan Rannan-Eliya; Donna M McDonald-McGinn; Elaine H Zackai; Steven A Wall; Maximilian Muenke; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2002-01-04       Impact factor: 11.025

4.  Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth.

Authors:  Thomas Amann; Frauke Bataille; Thilo Spruss; Katja Dettmer; Peter Wild; Christian Liedtke; Marcus Mühlbauer; Paul Kiefer; Peter J Oefner; Christian Trautwein; Anja-Katrin Bosserhoff; Claus Hellerbrand
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

5.  Q289P mutation in the FGFR2 gene: first report in a patient with type 1 Pfeiffer syndrome.

Authors:  Maria Piccione; Vincenzo Antona; Marcello Niceta; Carmelo Fabiano; Manuela Martines; Alberto Bianchi; Giovanni Corsello
Journal:  Eur J Pediatr       Date:  2008-12-06       Impact factor: 3.183

Review 6.  2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology.

Authors:  Richard J Epstein; Li Jun Tian; Yan Fei Gu
Journal:  J Oncol       Date:  2021-04-30       Impact factor: 4.375

7.  Heterozygous mutations of FREM1 are associated with an increased risk of isolated metopic craniosynostosis in humans and mice.

Authors:  Lisenka E L M Vissers; Timothy C Cox; A Murat Maga; Kieran M Short; Fenny Wiradjaja; Irene M Janssen; Fernanda Jehee; Debora Bertola; Jia Liu; Garima Yagnik; Kiyotoshi Sekiguchi; Daiji Kiyozumi; Hans van Bokhoven; Carlo Marcelis; Michael L Cunningham; Peter J Anderson; Simeon A Boyadjiev; Maria Rita Passos-Bueno; Joris A Veltman; Ian Smyth; Michael F Buckley; Tony Roscioli
Journal:  PLoS Genet       Date:  2011-09-08       Impact factor: 5.917

8.  A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.

Authors:  Sarah Siddiqui; Shilpi Chattopadhyay; Md Salman Akhtar; Mohammad Zeeshan Najm; S V S Deo; N K Shukla; Syed Akhtar Husain
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

9.  Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma.

Authors:  Hyo Jeong Lee; Hyo Jeong Kang; Kang Mo Kim; Eun Sil Yu; Ki Hun Kim; Seung-Mi Kim; Tae Won Kim; Ju Hyun Shim; Young-Suk Lim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee
Journal:  Clin Mol Hepatol       Date:  2015-03-25

10.  Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study.

Authors:  Hongmei Nan; Abrar A Qureshi; David J Hunter; Jiali Han
Journal:  BMC Cancer       Date:  2009-06-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.